Cas 849345-45-5,L-Proline, 4-[[4-[(3-chloro-2-fluorophenyl)amino]-7-quinazolinyl]oxy]-1-methyl-, methyl ester, (4S)-

849345-45-5

Post Buying Request

Basic information

Product Name: L-Proline, 4-[[4-[(3-chloro-2-fluorophenyl)amino]-7-quinazolinyl]oxy]-1-methyl-, methyl ester, (4S)-
Synonyms:
CAS NO:849345-45-5
Molecular Formula: C21H20ClFN4O3
Molecular Weight: 430.866
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: L-Proline, 4-[[4-[(3-chloro-2-fluorophenyl)amino]-7-quinazolinyl]oxy]-1-methyl-, methyl ester, (4S)-(CAS DataBase Reference)
NIST Chemistry Reference: L-Proline, 4-[[4-[(3-chloro-2-fluorophenyl)amino]-7-quinazolinyl]oxy]-1-methyl-, methyl ester, (4S)-(849345-45-5)
EPA Substance Registry System: L-Proline, 4-[[4-[(3-chloro-2-fluorophenyl)amino]-7-quinazolinyl]oxy]-1-methyl-, methyl ester, (4S)-(849345-45-5)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 849345-45-5(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

849345-45-5 Suppliers

Recommended suppliers

849345-45-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 849345-45-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,4,9,3,4 and 5 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 849345-45:
(8*8)+(7*4)+(6*9)+(5*3)+(4*4)+(3*5)+(2*4)+(1*5)=205
205 % 10 = 5
So 849345-45-5 is a valid CAS Registry Number.

849345-45-5Upstream product

849345-45-5Downstream Products

849345-40-0 (4S)-4-({4-[(3-chloro-2-fluorophenyl)amino]quinazolin-7-yl}oxy)-1-methyl-L-proline

849345-45-5Relevant academic research and scientific papers

QUINAZOLINE DERIVATIVES

-

Page/Page column 122, (2008/06/13)

The invention concerns a quinazoline derivative of the Formula (I): wherein each of the variables have any of the meanings defined in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use as an antiproliferative agent in the prevention or treatment of tumours which are sensitive to inhibition of erbB receptor tyrosine kinases.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 849345-45-5